A growing number of studies have shown that γδ T cells play a pivotal role in mediating the
clearance of tumors and pathogen-infected cells with their potent cytotoxic, cytolytic, and …

Although γδ T cells comprise a small population of T cells, they perform important roles in
protecting against infection and suppressing tumors. With their distinct tissue-localizing …

While cord blood (CB) is primarily utilized in allogeneic hematopoietic cell transplantation
(HCT), the development of novel cell therapy products from CB is a growing and developing …

Abstract γδ T cells play an important role in disease control in acute myeloid leukemia (AML)
and have become an emerging area of therapeutic interest. These cells represent a minor …

Relapse and refractoriness remain the major obstacles in clinical treatment of acute myeloid
leukemia (AML). Efficacy of current therapeutic strategies for relapsed/refractory (R/R) AML …

γδ T cells, a specialized subset of T lymphocytes, have garnered significant attention within
the realm of cancer immunotherapy. Operating at the nexus between adaptive and innate …

Unconventional T cells and innate lymphoid cells (ILCs) make up a heterogeneous set of
cells that characteristically show prompt responses toward specific antigens …

Human gamma-delta (γδ) T cells are a heterogeneous cell population that bridges the gap
between innate and acquired immunity. They are involved in a variety of immunological …

Vγ9Vδ2 T cells represent a promising cancer therapy platform because the implementation
of allogenic, off-the-shelf product candidates is possible. However, intravenous …

Cancer is one of the leading causes of death worldwide, and more effective ways of
attacking cancer are being sought. Cancer immunotherapy is a new and effective …